23 Publikationen

Alle markieren

  • [23]
    2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935652
    J. Witte, et al., “Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.”, Annals of oncology : official journal of the European Society for Medical Oncology, vol. 30, 2019, pp. 1061-1070.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [22]
    2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934071 OA
    S. Scholz, et al., “Population size and self-reported characteristics and sexual preferences of men-who-have-sex-with-men (MSM) in Germany based on social network data”, PLOS ONE, vol. 14, 2019, : e0212175.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [21]
    2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936903 OA
    S. Scholz, et al., “Epidemiology and cost of seasonal influenza in Germany - a claims data analysis”, BMC public health, vol. 19, 2019, : 1090.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [20]
    2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934052
    S. Sheikh, et al., “Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992].”, Vaccine, vol. 37, 2019, pp. 1374-1376.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [19]
    2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2917041
    J. Horn, et al., “Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study”, BMC MEDICINE, vol. 16, 2018, : 9.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [18]
    2018 | Bielefelder E-Dissertation | PUB-ID: 2932490 OA
    O. Damm, Die Anwendung von Modellierungsmethoden im Rahmen der gesundheitsökonomischen Evaluation von Impfungen in Deutschland, Bielefeld: Universität Bielefeld, 2018.
    PUB | PDF | DOI
     
  • [17]
    2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2931114
    S. Sheikh, et al., “A report on the status of vaccination in Europe”, VACCINE, vol. 36, 2018, pp. 4979-4992.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [16]
    2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2914076 OA
    O. Damm, et al., “Cost-effectiveness of human papillomavirus vaccination in Germany”, Cost Effectiveness and Resource Allocation, vol. 15, 2017, : 18.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [15]
    2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2911011
    L. Gerlier, et al., “Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model”, APPLIED HEALTH ECONOMICS AND HEALTH POLICY, vol. 15, 2017, pp. 261-276.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [14]
    2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916591
    P.T. de Boer, et al., “A systematic review of the health economic consequences of quadrivalent influenza vaccination”, Expert Review of Pharmacoeconomics & Outcomes Research, vol. 17, 2017, pp. 249-265.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [13]
    2016 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2902118
    B. Ultsch, et al., “Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community”, PHARMACOECONOMICS, vol. 34, 2016, pp. 227-244.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [12]
    2016 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2905960
    O. Damm, et al., “Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review”, INTERNATIONAL JOURNAL OF PUBLIC HEALTH, vol. 61, 2016, pp. 847-860.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [11]
    2016 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2906732
    L. Gerlier, et al., “Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium”, PEDIATRIC DRUGS, vol. 18, 2016, pp. 303-318.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [10]
    2015 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2758642
    O. Damm, et al., “Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany”, The European Journal of Health Economics, vol. 16, 2015, pp. 471-488.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [9]
    2015 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2758733 OA
    O. Damm, et al., “Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.”, BMC Public Health, vol. 15, 2015, : 533.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [8]
    2015 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2917091
    O. Damm and B. Ultsch, “Gesundheitsökonomische Evaluation von Impfungen”, Gesundheitsökonomie & Qualitätsmanagement, vol. 20, 2015, pp. 163-172.
    PUB | DOI | WoS
     
  • [7]
    2014 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2661294 OA
    M.A. Rose, et al., “The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study”, BMC Infectious Diseases, vol. 14, 2014, : 40.
    PUB | PDF | DOI | WoS | PubMed | Europe PMC
     
  • [6]
    2013 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2607268
    J. Horn, et al., “Estimating the long-term effects of HPV vaccination in Germany”, Vaccine, vol. 31, 2013, pp. 2372-2380.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [5]
    2013 | Report | PUB-ID: 2686145 OA
    J. Horn, et al., Langfristige epidemiologische und ökonomische Auswirkungen der HPV-Impfung in Deutschland. Überarbeiteter Abschlussbericht, Berlin: Robert Koch-Institut, 2013.
    PUB | PDF
     
  • [4]
    2012 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2553505
    O. Damm, F. Leppert, and W. Greiner, “Cost of illness of common cancer types - Results of a health insurance claims data analysis”, Value In Health, vol. 15, 2012, pp. A417.
    PUB | DOI | WoS
     
  • [3]
    2012 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2474515
    R.T. Mikolajczyk, et al., “Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections”, JNCI Journal of the National Cancer Institute, vol. 104, 2012, pp. 163.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [2]
    2012 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2530533
    J. Breckenkamp, et al., “Abgleich von Verwaltungsdaten des Medizinischen Dienstes der Krankenversicherung mit Krebsregisterdaten”, Das Gesundheitswesen, vol. 74, 2012, pp. e52-e60.
    PUB | DOI | WoS | PubMed | Europe PMC
     
  • [1]
    2009 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 1589642
    O. Damm and W. Greiner, “COST-EFFECTIVENESS OF HPV VACCINATION-AN OVERVIEW ON INTERNATIONAL STUDY RESULTS”, Value in Health, VALUE IN HEALTH, vol. 12, Elsevier BV, 2009, pp.A277.
    PUB | DOI | WoS
     

Suche

Publikationen filtern

Darstellung / Sortierung

Export / Einbettung